Cover Image
市場調查報告書

MediPoint:生物外科 - 全球市場的分析與預測

MediPoint: Biosurgery - Global Analysis and Market Forecast

出版商 GlobalData 商品編碼 370545
出版日期 內容資訊 英文 175 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:生物外科 - 全球市場的分析與預測 MediPoint: Biosurgery - Global Analysis and Market Forecast
出版日期: 2016年06月14日 內容資訊: 英文 175 Pages
簡介

本報告提供全球生物外科 (生物外科手術) 市場相關調查分析,市場進入,未滿足需求,競爭評估,主要企業,市場預測等系統性資訊。

第1章 目錄

第2章 簡介

第3章 市場進入

  • 償付
  • 法規
  • 主要的M&A、交易、聯盟

第4章 未滿足需求

  • 概要
  • 最適合的動態特性
  • 準備和保管
  • 安全上的疑慮
  • 更佳的生物適合性
  • 止血劑的緊急時、軍事利用

第5章 競爭評估

  • 企業佔有率分析
  • 主要企業
  • 新興企業
  • 經銷商

第6章 市場預測

  • 推動市場要素、障礙
  • 市場預測:各市場區隔
  • 市場預測:各地區
  • 市場區隔佔有率:各國

第7章 附錄

目錄
Product Code: GDME0229MAR

Prompt hemostasis, effective incision closure, tissue and vessel sealing, and post-operative adhesion prevention have been paramount concerns for surgeons for decades. As medical technology advances, the surgeon's toolbox expands to include more effective products that actively cease bleeding, close external and internal ruptures in tissue, and provide physical barriers between tissues to prevent dangerous adhesions. These biosurgery products have become indispensable keystones in any operating room environment.

Biosurgery products are experiencing steady growth across many countries. Emerging markets are expected to demonstrate the highest growth among the 15 market covered in the report, which are the US, Canada, Mexico, France, Germany, Italy, Spain, Russia, UK, Japan, China, India, South Korea, Australia, and Brazil.

The taxonomy of biosurgery included in this report covers hemostats, tissue sealants, tissue adhesives, and surgical adhesion barriers.

The global biosurgery market features two main players: J&J and Baxter. Other prominent players include CryoLife, Sanofi, Pfizer, Integra LifeSciences, C.R. Bard, and B. Braun.

The entire market will be driven by aging populations, higher volumes of surgical procedures, and an increasing number of technological innovations.

Key Opinion Leaders emphasize the need for better mechanical properties, optimal biocompatibility, and need for less expensive products.

Highlights

Key Questions Answered

  • What is the current and future biosurgery market outlook in the developed and emerging markets? What trends are affecting the global market?
  • Which are the key, high growth sectors of interest? Which markets segments are growing the fastest?
  • What are the unmet needs with biosurgery products currently on the market? How will future developments fulfill these unmet needs?
  • What are the physician perception s of biosurgery products?
  • What are the challenges that have hindered widespread adoption?
  • How will emerging trends and changing market landscapes affect the future of this space?

Key Findings

  • Emerging economies are seeing the highest growth in the global biosurgery market.
  • Hemostats and tissue sealants make up the largest portions of the market in many countries because they are widely used in a variety of different surgical specialties.
  • The most successful firms involved in biosurgery are providing comprehensive portfolios, undertaking key M&A's, fostering innovation, and focusing wisely on emerging markets to stay competitive.
  • Rising numbers of different surgical procedures are the primary drivers of the biosurgery market. Despite respectable adoption, unmet needs and non-clinical barriers remain a challenge.

Scope

  • Overview of different hemostats, sealants, adhesives, and adhesion prevention products available to surgeons.
  • Annualized total biosurgery market revenue by segment and market outlooks by country through 2022.
  • Key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access, and implications of the emerging technologies on the market.
  • Analysis of the current and future market competition in the biosurgery market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global biosurgery market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific markets from 2013-2022.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Market Access

  • 3.1. Reimbursement
  • 3.2. Regulation
    • 3.2.1. North America
    • 3.2.2. Europe
    • 3.2.3. Asia-Pacific
  • 3.3. Key Mergers, Acquisitions, Deals, and Partnerships

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Optimal Mechanical Properties
  • 4.3. Preparation and Storage
  • 4.4. Safety Concerns
  • 4.5. Better Biocompatibility
  • 4.6. Emergency and Military Use of Hemostats

5. Competitive Assessment

  • 5.1. Company Share Analysis
    • 5.1.1. Global Overview
    • 5.1.2. North America
    • 5.1.3. Europe
    • 5.1.4. Asia-Pacific
  • 5.2. Major Players
    • 5.2.1. Advanced Medical Solutions
    • 5.2.2. B. Braun
    • 5.2.3. Atrium Medical
    • 5.2.4. Baxter
    • 5.2.5. C.R. Bard
    • 5.2.6. CryoLife
    • 5.2.7. Gelita
    • 5.2.8. Sanofi
    • 5.2.9. Integra LifeSciences
    • 5.2.10. Ethicon Endo-Surgery (Johnson & Johnson)
    • 5.2.11. Medtronic
    • 5.2.12. Pfizer
    • 5.2.13. Stryker
    • 5.2.14. Takeda
  • 5.3. Emerging Players
    • 5.3.1. 3-D Matrix Medical Technology
    • 5.3.2. Adhezion Biomedical
    • 5.3.3. Anika Therapeutics
    • 5.3.4. BioActive Polymers
    • 5.3.5. Chemence Medical
    • 5.3.6. Cohera Medical
    • 5.3.7. Gecko Biomedical
    • 5.3.8. Hemostasis, LLC
    • 5.3.9. HyperBranch Medical Technology
    • 5.3.10. Mallinckrodt
    • 5.3.11. Mast Biosurgery
    • 5.3.12. OptMed
    • 5.3.13. Sealantis
    • 5.3.14. Vivostat
  • 5.4. Distributors

6. Market Outlooks

  • 6.1. Market Drivers and Barriers
    • 6.1.1. Driver: Growing Surgery Markets
    • 6.1.2. Driver: Curtailing the Impact of Excessive Blood Loss
    • 6.1.3. Driver: The Multi-functionality of Fibrin
    • 6.1.4. Driver: Novel Materials and Advanced Features
    • 6.1.5. Barrier: Growth of Laparoscopic Procedures
    • 6.1.6. Barrier: Mechanical Wound Closure Devices
    • 6.1.7. Barrier: Coagulation and Tissue Sealing Using Surgical Energy
    • 6.1.8. Barrier: Steep Costs
    • 6.1.9. Barrier: Regulatory Problems
  • 6.2. Market Outlooks by Segment
    • 6.2.1. Global Overview
    • 6.2.2. Hemostats
    • 6.2.3. Tissue Sealants
    • 6.2.4. Tissue Adhesives
    • 6.2.5. Surgical Adhesion Barriers
  • 6.3. Market Outlooks by Geography
    • 6.3.1. Global Overview
    • 6.3.2. North America
    • 6.3.3. Europe
    • 6.3.4. Asia-Pacific
    • 6.3.5. South America (Brazil)
  • 6.4. Segment Share by Country
    • 6.4.1. US
    • 6.4.2. Canada
    • 6.4.3. Mexico
    • 6.4.4. France
    • 6.4.5. Germany
    • 6.4.6. Italy
    • 6.4.7. Russia
    • 6.4.8. Spain
    • 6.4.9. UK
    • 6.4.10. Australia
    • 6.4.11. China
    • 6.4.12. India
    • 6.4.13. Japan
    • 6.4.14. South Korea
    • 6.4.15. Brazil

7. Appendix

  • 7.1. Bibliography
  • 7.2. Abbreviations
  • 7.3. Methodology
    • 7.3.1. Overview
    • 7.3.2. Coverage
    • 7.3.3. Secondary Research
  • 7.4. Forecasting Methodology
  • 7.5. Primary Research Efforts
  • 7.6. About the Authors
    • 7.6.1. Shashank Settipalli, Analyst, Medical Devices
    • 7.6.2. Linda Tian, Msc, Managing Analyst, Medical Devices
    • 7.6.3. David Brady, Director of Operations - Market Research
    • 7.6.4. Tyler Fletcher, Global Head of Medical Devices
  • 7.7. About GlobalData
  • 7.8. Disclaimer

List of Tables

  • Table 1: Sample HCPCS Codes for Biosurgery Products
  • Table 2: Recent FDA Approvals and Clearances of Biosurgery Products
  • Table 3: Key Deals in the Biosurgery Space (2013-2016)
  • Table 4: Advanced Medical Solutions Company Profile
  • Table 5: Advanced Medical Solutions SWOT Analysis, 2016
  • Table 6: Key Marketed Products from Advanced Medical Solutions
  • Table 7: B. Braun Company Profile
  • Table 8: B. Braun SWOT Analysis, 2016
  • Table 9: Key Marketed Products from B. Braun
  • Table 10: Atrium Medical Company Profile
  • Table 11: Getinge SWOT Analysis, 2016
  • Table 12: Key Marketed Products from Atrium Medical
  • Table 13: Baxter Company Profile
  • Table 14: Baxter SWOT Analysis, 2016
  • Table 15: Key Marketed Products from Baxter
  • Table 16: C.R. Bard Company Profile
  • Table 17: C.R. Bard SWOT Analysis, 2016
  • Table 18: Key Marketed Products from C.R. Bard
  • Table 19: CryoLife Company Profile
  • Table 20: CryoLife SWOT Analysis, 2016
  • Table 21: Key Marketed Products from CryoLife
  • Table 22: Gelita Company Profile
  • Table 23: Gelita SWOT Analysis, 2016
  • Table 24: Key Marketed Products from Gelita
  • Table 25: Sanofi Company Profile
  • Table 26: Sanofi SWOT Analysis, 2016
  • Table 27: Key Marketed Products from Sanofi
  • Table 28: Integra LifeSciences Company Profile
  • Table 29: Integra LifeSciences SWOT Analysis, 2016
  • Table 30: Key Marketed Products from Integra Lifesciences
  • Table 31: Ethicon Company Profile
  • Table 32: Ethicon SWOT Analysis, 2016
  • Table 33: Key Marketed Products from Ethicon
  • Table 34: Medtronic Company Profile
  • Table 35: Medtronic SWOT Analysis, 2016
  • Table 36: Key Marketed Products from Medtronic
  • Table 37: Pfizer Company Profile
  • Table 38: Pfizer SWOT Analysis, 2016
  • Table 39: Key Marketed Products from Pfizer
  • Table 40: Stryker Company Profile
  • Table 41: Stryker SWOT Analysis, 2016
  • Table 42: Key Marketed Products from Stryker
  • Table 43: Takeda Company Profile
  • Table 44: Takeda SWOT Analysis, 2016
  • Table 45: Key Marketed Products from Takeda
  • Table 46: 3-D Matrix Medical Technology Company Profile
  • Table 47: 3-D Matrix Medical Technology SWOT Analysis, 2016
  • Table 48: Key Marketed Products from 3-D Matrix Medical Technology
  • Table 49: Adhezion Biomedical Company Profile
  • Table 50: Key Marketed Products from Adhezion Biomedical
  • Table 51: Anika Therapeutics Company Profile
  • Table 52: Key Marketed Products from Anika Therapeutics
  • Table 53: BioActive Polymers Company Profile
  • Table 54: Key Pipeline Products from BioActive Polymers
  • Table 55: Chemence Medical Company Profile
  • Table 56: Key Marketed Products from Chemence Medical
  • Table 57: Cohera Medical Company Profile
  • Table 58: Key Marketed Products from Advanced Medical Solutions
  • Table 59: Gecko Biomedical Company Profile
  • Table 60: Hemostasis Company Profile
  • Table 61: Key Marketed Products from Hemostasis
  • Table 62: HyperBranch Company Profile
  • Table 63: Key Marketed Products from Hemostasis
  • Table 64: Mallinckrodt Company Profile
  • Table 65: Key Marketed Products from Mallinckrodt
  • Table 66: Mast Biosurgery Company Profile
  • Table 67: Key Marketed Products from Mast Biosurgery
  • Table 68: OptMed Company Profile
  • Table 69: Key Marketed Products from OptMed
  • Table 70: Sealantis Company Profile
  • Table 71: Key Marketed Products from Sealantis
  • Table 72: Vivostat Company Profile
  • Table 73: Major Distributors of Biosurgery Products
  • Table 74: Global Market Value Forecast by Segment for Biosurgery, $m, 2013-2022
  • Table 75: North America Market Value Forecast by Segment for Hemostats, $m, 2013-2022
  • Table 76: Europe Market Value Forecast by Segment for Hemostats, $m, 2013-2022
  • Table 77: Asia-Pacific Market Value Forecast by Segment for Hemostats, $m, 2013-2022
  • Table 78: Brazil Market Value Forecast by Segment for Hemostats, $m, 2013-2022
  • Table 79: North America Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 80: Europe Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 81: Asia-Pacific Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 82: Brazil Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 83: North America Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 84: Europe Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 85: Asia-Pacific Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 86: Brazil Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
  • Table 87: North America Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
  • Table 88 : Europe Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
  • Table 89 : Asia-Pacific Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
  • Table 90 : Brazil Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
  • Table 91 : Global Market Value Forecast by Country for Biosurgery, $m, 2013-2022

List of Figures

  • Figure 1: Global Company Market Share for Biosurgery, 2015
  • Figure 2: North America Company Market Share for Biosurgery, 2015
  • Figure 3: Europe Company Market Share for Biosurgery, 2015
  • Figure 4: Global Market Forecast for Biosurgery by Segment, 2013-2022
  • Figure 5: Global Market Forecast for Hemostats by Segment, 2013-2022
  • Figure 6: North America Market Forecast for Hemostats by Segment, 2013-2022
  • Figure 7: Europe Market Forecast for Hemostats by Segment, 2013-2022
  • Figure 8: Asia-Pacific Market Forecast for Hemostats by Segment, 2013-2022
  • Figure 9: Brazil Market Forecast for Hemostats by Segment, 2013-2022
  • Figure 10: Global Market Forecast for Tissue Sealants by Segment, 2013-2022
  • Figure 11: North America Market Forecast for Tissue Sealants by Segment, 2013-2022
  • Figure 12: Europe Market Forecast for Tissue Sealants by Segment, 2013-2022
  • Figure 13: Asia-Pacific Market Forecast for Tissue Sealants by Segment, 2013-2022
  • Figure 14: Brazil Market Forecast for Tissue Sealants by Segment, 2013-2022
  • Figure 15: Global Market Forecast for Tissue Adhesives by Segment, 2013-2022
  • Figure 16: North America Market Forecast for Tissue Adhesives by Segment, 2013-2022
  • Figure 17: Europe Market Forecast for Tissue Adhesives by Segment, 2013-2022
  • Figure 18: Asia-Pacific Market Forecast for Tissue Adhesives by Segment, 2013-2022
  • Figure 19: Brazil Market Forecast for Tissue Adhesives by Segment, 2013-2022
  • Figure 20: Global Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
  • Figure 21: North America Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
  • Figure 22: Europe Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
  • Figure 23: Asia-Pacific Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
  • Figure 24: Brazil Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
  • Figure 25: Global Market Forecast for Biosurgery by Country, 2013-2022
  • Figure 26: Global Biosurgery Market Comparison by Country, 2015 and 2022
  • Figure 27: Global Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
  • Figure 28: Global Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
  • Figure 29: Global Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
  • Figure 30: North America Market Forecast for Biosurgery by Country, 2013-2022
  • Figure 31: North America Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
  • Figure 32: North America Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
  • Figure 33: North America Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
  • Figure 34: Europe Market Forecast for Biosurgery by Country, 2013-2022
  • Figure 35: Europe Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
  • Figure 36: Europe Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
  • Figure 37: Europe Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
  • Figure 38: Asia-Pacific Market Forecast for Biosurgery by Country, 2013-2022
  • Figure 39: Asia-Pacific Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
  • Figure 40: Asia-Pacific Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
  • Figure 41: Asia-Pacific Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
  • Figure 42: Brazil Market Forecast for Biosurgery by Country, 2013-2022
  • Figure 43: Brazil Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
  • Figure 44: Brazil Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
  • Figure 45: Brazil Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
  • Figure 46: US Biosurgery Market Share by Segment, 2015
  • Figure 47: Canada Biosurgery Market Share by Segment, 2015
  • Figure 48: Mexico Biosurgery Market Share by Segment, 2015
  • Figure 49: France Biosurgery Market Share by Segment, 2015
  • Figure 50: Germany Biosurgery Market Share by Segment, 2015
  • Figure 51: Italy Biosurgery Market Share by Segment, 2015
  • Figure 52: Russia Biosurgery Market Share by Segment, 2015
  • Figure 53: Spain Biosurgery Market Share by Segment, 2015
  • Figure 54: UK Biosurgery Market Share by Segment, 2015
  • Figure 55: Australia Biosurgery Market Share by Segment, 2015
  • Figure 56: China Biosurgery Market Share by Segment, 2015
  • Figure 57: India Biosurgery Market Share by Segment, 2015
  • Figure 58: Japan Biosurgery Market Share by Segment, 2015
  • Figure 59: South Korea Biosurgery Market Share by Segment, 2015
  • Figure 60: Brazil Biosurgery Market Share by Segment, 2015
Back to Top